The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies

被引:11
|
作者
Norman, Jane E. [1 ]
Schouten, Harry C. [2 ]
Dreger, Peter [3 ]
Robinson, Stephen P. [4 ]
机构
[1] Manchester Royal Infirm, Dept Haematol, Manchester, Lancs, England
[2] Univ Hosp Maastricht, Dept Internal Med Hematol, Maastricht, Netherlands
[3] Heidelberg Univ, Dept Haematol & Oncol, Heidelberg, Germany
[4] Bristol Oncol & Haematol Ctr, Dept Haematol, Bristol, Avon, England
关键词
NON-HODGKIN-LYMPHOMA; TERM-FOLLOW-UP; BONE-MARROW-TRANSPLANTATION; PROGRESSION-FREE SURVIVAL; HIGH-DOSE THERAPY; CHRONIC LYMPHOCYTIC-LEUKEMIA; CHIMERIC-ANTIGEN-RECEPTOR; LOW-GRADE; OPEN-LABEL; PHASE-II;
D O I
10.1038/s41409-018-0372-5
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Patients with relapsed follicular lymphoma (FL) following first-line therapy have an increasing number of management strategies ranging from observation through to stem cell transplantation. There has been an exciting expansion in novel agents to treat FL, but at present there is not a universally accepted standard of care in the relapse setting. Decision-making can be difficult for the clinician as there is a paucity of data to compare the various relapse therapies available. This review will discuss conventional therapy for relapsed FL, consider the use of novel agents and explore the role and timing of autologous and allogeneic stem cell transplantation.
引用
收藏
页码:787 / 797
页数:11
相关论文
共 50 条
  • [1] The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era
    Maura, Francesco
    Farina, Lucia
    Corradini, Paolo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2016, 8
  • [2] Role of Hematopoietic Stem Cell Transplant in the Management of Follicular Lymphoma
    Foster, Matthew
    Gabriel, Don A.
    Shea, Thomas
    ONCOLOGIST, 2009, 14 (07) : 726 - 738
  • [4] Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era
    Sesques, Pierre
    Bourcier, Jessie
    Golfier, Camille
    Lebras, Laure
    Nicolas-Virelizier, Emmanuelle
    Hacini, Maya
    Perrin, Marie Claire
    Voillat, Laurent
    Bachy, Emmanuel
    Traverse-Glehen, Alexandra
    Moreau, Anne
    Martin, Laurent
    Ramla, Selim
    Casasnovas, Olivier
    Le Gouill, Steven
    Salles, Gilles
    Ghesquieres, Herve
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (02) : 137 - 145
  • [5] Changing role of stem cell transplantation in follicular lymphoma
    Laport, Ginna G.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, : 417 - 425
  • [6] Stem Cell Transplantation for Follicular Lymphoma Relapsed/Refractory After Prior Rituximab
    Evens, Andrew M.
    Vanderplas, Ann
    LaCasce, Ann S.
    Crosby, Allison L.
    Nademanee, Auayporn P.
    Kaminski, Mark S.
    Abel, Gregory A.
    Millenson, Michael
    Czuczman, Myron S.
    Rodriguez, Maria A.
    Niland, Joyce
    Zelenetz, Andrew D.
    Gordon, Leo I.
    Friedberg, Jonathan W.
    CANCER, 2013, 119 (20) : 3662 - 3671
  • [7] The Role of Hematopoietic Stem Cell Transplant in Follicular Lymphoma
    Faber, Edward A., Jr.
    Vose, Julie M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (03): : 337 - 345
  • [8] Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma
    Bhatt, V. R.
    Armitage, J. O.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (01) : 57 - 66
  • [9] The role of autologous stem-cell transplantation in classical Hodgkin lymphoma in the modern era
    Varma, Gaurav
    Diefenbach, Catherine
    SEMINARS IN HEMATOLOGY, 2024, 61 (04) : 253 - 262
  • [10] Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies
    Rainone, Michael
    Siddiqi, Tanya
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (01) : 39 - 45